Although there was no statistical reduction in cd107a, and IFN-γ in the NASH-FMT group, presumably owing to excessive discrepancy within the group and insufficient sample size, the reduction in Granzyme B showed a statistical difference. This evidence concerns the gene LAMP1 and metabolic dysfunction-associated steatohepatitis.